Adenosine release: A potential explanation for the benefits of ticagrelor in the PLATelet Inhibition and Clinical Outcomes trial?

American Heart Journal

Volumn 161, Issue 1, 2011, Pages 1-4

  Serebruany, Victor L ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; ADENOSINE A1 RECEPTOR; ADENOSINE A2 RECEPTOR; ADENOSINE A2A RECEPTOR; ADENOSINE A2B RECEPTOR; ADENOSINE A3 RECEPTOR; CLOPIDOGREL; MITOGEN ACTIVATED PROTEIN KINASE; PURINERGIC P2Y12 RECEPTOR; TICAGRELOR;

ACUTE CORONARY SYNDROME; ACUTE HEART FAILURE; CANCER INHIBITION; CONGESTIVE HEART FAILURE; DYSPNEA; HEART ARRHYTHMIA; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE PERFUSION; HEART PROTECTION; HUMAN; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RECEPTOR BLOCKING; REVIEW; SIDE EFFECT; STROKE; SUDDEN DEATH; THROMBOCYTE AGGREGATION INHIBITION;

EID: 78650289551     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2010.09.017     Document Type: Editorial

References (30)

1. Wallentin L., Becker R.C., and Budaj A. The PLATO Investigators. Ticagrelor versus clopidogrel in patients with acute coronary syndromes N Engl J Med 361 2009 1045 1057
2. Jacobson K.A., Mamedova L., and Joshi B.V. Molecular recognition at adenine nucleotide (P2) receptors in platelets Semin Thromb Hemost 31 2005 205 216 (Pubitemid 40605195)
3. Husted S., Emanuelsson H., and Heptinstall S. Pharmacodynamics, pharmacokinetics, and safety of the oral reversible P2Y12 antagonist AZD6140 with aspirin in patients with atherosclerosis: a double-blind comparison to clopidogrel with aspirin Eur Heart J 27 2006 1038 1047
4. Linden J. Molecular approach to adenosine receptors: receptor-mediated mechanisms of tissue protection Annu Rev Pharmacol Toxicol 41 2001 775 787 (Pubitemid 32385906)
5. Fredholm B.B., AP I.J., and Jacobson K.A. International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors Pharmacol Rev 53 2001 527 552
6. Jacobson K.A. Introduction to adenosine receptors as therapeutic targets Handb Exp Pharmacol 193 2009 1 24
7. Mahaffey K.W., Puma J.A., and Barbagelata N.A. Adenosine as an adjunct to thrombolytic therapy for acute myocardial infarction: results of a multicenter, randomized, placebo-controlled trial: the Acute Myocardial Infarction STudy of ADenosine (AMISTAD) trial J Am Coll Cardiol 34 1999 1711 1720
8. Ross A.M., Gibbons R.J., and Stone G.W. AMISTAD-II Investigators. A randomized, double-blinded, placebo-controlled multicenter trial of adenosine as an adjunct to reperfusion in the treatment of acute myocardial infarction (AMISTAD-II) J Am Coll Cardiol 45 2005 1775 1780
9. Quintana M., Hjemdahl P., and Sollevi A. ATTACC Investigators. Left ventricular function and cardiovascular events following adjuvant therapy with adenosine in acute myocardial infarction treated with thrombolysis: results of the ATTenuation by Adenosine of Cardiac Complications (ATTACC) study Eur J Clin Pharmacol 59 2003 1 9 (Pubitemid 36702752)
10. Eltzschig H.K. Adenosine: an old drug newly discovered Anesthesiology 111 2009 904 915
11. Mader T.J., Menegazzi J.J., and Rittenberger J.C. The effect of adenosine A1 receptor antagonism on return of spontaneous circulation and short-term survival in prolonged ventricular fibrillation Prehosp Emerg Care 12 2008 352 358
12. Englert H.C., Heitsch H., and Gerlach U. Blockers of the ATP-sensitive potassium channel SUR2A/Kir6.2: a new approach to prevent sudden cardiac death Curr Med Chem Cardiovasc Hematol Agents 1 2003 253 271
13. Shah R.H., and Frishman W.H. Adenosine1 receptor antagonism: a new therapeutic approach for the treatment of decompensated heart failure Cardiol Rev 17 2009 125 131
14. Dai W., Hale S.L., and Nayak R. ATL 313, a selective A(2A) adenosine receptor agonist, reduces myocardial infarct size in a rat ischemia/reperfusion model Open Cardiovasc Med J 3 2009 166 172
15. Takahama H., Minamino T., and Asanuma H. Prolonged targeting of ischemic/reperfused myocardium by liposomal adenosine augments cardioprotection in rats J Am CollCardiol 53 2009 709 717
16. Chen L., Fredholm B.B., and Jondal M. Adenosine, through the A1 receptor, inhibits vesicular MHC class I cross-presentation by resting DC Mol Immunol 45 2008 2247 2254
17. Jacobson K.A., Hoffmann C., and Cattabeni F. Adenosine-induced cell death: evidence for receptor-mediated signaling Apoptosis 4 1999 197 211 (Pubitemid 29378788)
18. Fishman P., Bar-Yehuda S., and Synowitz M. Adenosine receptors and cancer Handb Exp Pharmacol 193 2009 399 441
19. Jajoo S., Mukherjea D., and Watabe K. Adenosine A(3) receptor suppresses prostate cancer metastasis by inhibiting NADPH oxidase activity Neoplasia 11 2009 1132 1145
20. Fredholm B.B., Irenius E., and Kull B. Comparison of the potency of adenosine as an agonist at human adenosine receptors expressed in Chinese hamster ovary cells Biochem Pharmacol 61 2001 443 448 (Pubitemid 32168226)
21. Fredholm B.B. Adenosine, an endogenous distress signal, modulates tissue damage and repair Cell Death Differ 14 2007 1315 1323
22. Reynolds S.M., Docherty R., and Robbins J. Adenosine induces a cholinergic tracheal reflex contraction in guinea pigs in vivo via an adenosine A1 receptor-dependent mechanism J Appl Physiol 105 2008 187 196
23. Hua X., Erikson C.J., and Chason K.D. Involvement of A1 adenosine receptors and neural pathways in adenosine-induced bronchoconstriction in mice Am J Physiol Lung Cell Mol Physiol 293 2007 25 32 (Pubitemid 47080711)
24. Polosa R., and Holgate S.T. Adenosine receptors as promising therapeutic targets for drug development in chronic airway inflammation Curr Drug Targets 7 2006 699 706 (Pubitemid 43827266)
25. Ryzhov S., Ryzhov S., and Zaynagetdinov R. Effect of A2B adenosine receptor gene ablation on proinflammatory adenosine signaling in mast cells J Immunol 180 2008 7212 7220 (Pubitemid 351185857)
26. Robinson M.C., Thielmeier K.A., and Hill B.B. Transient ventricular asystole using adenosine during minimally invasive and open sternotomy coronary artery bypass grafting Ann Thorac Surg 63 6 Suppl 1997 S30 S34
27. Carrega L., Saadjian A.Y., and Mercier L. Increased expression of adenosine A2A receptors in patients with spontaneous and head-up-tilt-induced syncope Heart Rhythm 4 2007 870 876 (Pubitemid 46959197)
28. Fredholm B.B., Chern Y., and Franco R. Aspects of the general biology of adenosine A2A signaling Prog Neurobiol 83 2007 263 2376 (Pubitemid 350102746)
29. Van Giezen J.J., Nilsson L., and Berntsson P. Ticagrelor binds to human P2Y(12) independently from ADP but antagonizes ADP-induced receptor signaling and platelet aggregation J Thromb Haemost 7 2009 1556 1565
30. Aurigemma C., Scalone G., and Fattorossi A. Adenosine inhibition of adenosine diphosphate and thrombin-induced monocyte-platelet aggregates in cardiac syndrome X Thromb Res 124 2009 116 120